Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | FGF1 | P05230 | 1/20 | 0.40 |
| ▸ | FGF2 | P09038 | 1/20 | 0.40 |
| ▸ | VEGFA | P15692 | 1/20 | 0.40 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.39 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3290451 | 0.83 | SLC5A2 (0.53) | — | |
| SCHEMBL29508765 | 0.78 | FBP1 (0.48) | — | |
| SCHEMBL769912 | 0.78 | FBP1 (0.48) | — | |
| SCHEMBL14742691 | 0.78 | FBP1 (0.48) | — | |
| SCHEMBL769262 | 0.76 | ADORA1 (0.45) | ADORA1FGF1FGF2VEGFAHPSE | |
| Pyrophosphoric Acid SCHEMBL14742591 | 0.76 | FBP1 (0.45) | — | |
| SCHEMBL860142 | 0.73 | ADORA1 (0.37) | ADORA1FGF1FGF2VEGFAHPSE | |
| SCHEMBL783243 | 0.72 | LGALS8 (0.41) | ADORA1 | |
| SCHEMBL10773805 | 0.70 | SLC5A1 (0.44) | FGF1FGF2VEGFAHPSE | |
| SCHEMBL10788242 | 0.70 | SLC5A1 (0.44) | FGF1FGF2VEGFAHPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014217-A1 | COMPOSITIONS AND METHODS FOR BACTERIOPHAGE INFECTION OF STAPHYLOCOCCUS BACTERIA | WISCONSIN ALUMNI RES FOUND (US) | 2026-01-15 | — | — | US | disclosed |
| US-12416015-B2 | Multiplex production and barcoding of genetically engineered cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250179576-A1 | MICROBIAL SIGNATURES OF AUTISM SPECTRUM DISORDER | PITON THERAPEUTICS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-115851688-B | TrpCF mutant and application thereof | 胡丹 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025042804-A1 | RECOMBINANT PRODUCTION OF CYCLIC DINUCLEOTIDES | UNIVERSITY OF HOUSTON SYSTEM (US) | 2025-02-27 | — | — | WO | disclosed |
| US-20240368535-A1 | BURDEN-ADDICTED PRODUCTION STRAINS | ENDURO GENETICS APS (DK) | 2024-11-07 | — | — | US | disclosed |
| US-20240360466-A1 | ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION | BOARD OF TRUSTEES OF OMICHIGAN STATE UNIVERSITY | 2024-10-31 | — | — | US | disclosed |
| WO-2023225667-A2 | RECOMBINANT BACTERIA FOR PRODUCTION OF INDOLE-3-ACETIC ACID (IAA) AND USES THEREOF | SYNLOGIC OPERATING COMPANY, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230172997-A1 | RECOMBINANT BACTERIA FOR PRODUCTION OF INDOLE-3-ACETIC ACID (IAA) AND USES THEREOF | SYNLOGIC OPERATING COMPANY, INC. | 2023-06-08 | — | — | US | disclosed |
| CN-109423468-B | Method for increasing yield of compound and derivative thereof in aromatic amino acid biosynthesis pathway | 中国科学院微生物研究所 | 2022-12-20 | — | — | CN | disclosed |
| WO-2001039777-A1 | COMPOUNDS SPECIFIC TO ADENOSINE A1 A2A, AND A3 RECEPTORS AND USES THEREOF | OSI PHARMACEUTICALS, INC. (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-1082120-A1 | PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE | OSI Pharmaceuticals, Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999063099-A1 | FUNCTIONAL EXPRESSION OF ADENOSINE RECEPTORS IN YEAST | CADUS PHARMACEUTICAL CORPORATION (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999062518-A1 | PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE | OSI PHARMACEUTICALS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0698218-B1 | LABELLED CARBOHYDRATES AND THEIR USE IN ASSAYS | OXFORD GLYCOSCIENCES UK LTD (GB) | 1999-10-27 | — | — | EP | disclosed |
| WO-1999049013-A2 | TRYPTOPHAN BIOSYNTHETIC ENZYMES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| US-5747347-A | DISTINGUISHING BETWEEN CARBOHYDRATES IN MIXTURE BY LABELLING AT REDUCING TERMINAL WITH HYDROPHILIC FLUORESCENT MOIETY, SEPARATING BY DETECTING LABEL | OXFORD GLYCOSYSTEMS LTD. (GB) | 1998-05-05 | — | — | US | disclosed |
| EP-0698218-A1 | LABELLED CARBOHYDRATES AND THEIR USE IN ASSAYS | Oxford GlycoSciences (UK) Limited (GB) | 1996-02-28 | — | — | EP | disclosed |
| WO-1994028423-A1 | LABELLED CARBOHYDRATES AND THEIR USE IN ASSAYS | OXFORD GLYCOSYSTEMS LTD. (GB) | 1994-12-08 | — | — | WO | disclosed |
| EP-0154133-B1 | PLASMIDIC EXPRESSION VEHICLES, AND METHOD OF PRODUCING A POLYPEPTIDE THEREWITH | GENENTECH, INC. (US) | 1990-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014217-A1 | COMPOSITIONS AND METHODS FOR BACTERIOPHAGE INFECTION OF STAPHYLOCOCCUS BACTERIA | UPF1, POLL, O60361 | ADORA1 2521/4885FGF1 1411/4885FGF2 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.